4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-057865
Chief Technology Officer sold 3,616 shares at $5.82 ($21,057)
- Chief Technology Officer acquired 7,187 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herzich Paul Chief Technology Officer | 2026-02-13 | Option exercise 10b5-1 | +7,187 | 76,254 | D | ||
| Herzich Paul Chief Technology Officer | 2026-02-18 | Sale 10b5-1 | −3,616 | $5.82 | $21,057 | 72,638 | D |
| Derivatives | |||||||
| Herzich Paul Chief Technology Officer | 2026-02-13 | Option exercise · Restricted Stock Units 10b5-1 | −7,187 | 14,376 | D | ||
| Open-market sales · 3,616 sh · avg $5.82 · $21,057 | |||||||
Loading xslF345X05/ownership.xml…